Gabryelewicz A. Lanzul – eleven years after introduction to the Polish pharmaceutical market. Gastroenterology Review/Przegląd Gastroenterologiczny. 2009;4(2):71-73.
APA
Gabryelewicz, A. (2009). Lanzul – eleven years after introduction to the Polish pharmaceutical market. Gastroenterology Review/Przegląd Gastroenterologiczny, 4(2), 71-73.
Chicago
Gabryelewicz, Antoni. 2009. "Lanzul – eleven years after introduction to the Polish pharmaceutical market". Gastroenterology Review/Przegląd Gastroenterologiczny 4 (2): 71-73.
Harvard
Gabryelewicz, A. (2009). Lanzul – eleven years after introduction to the Polish pharmaceutical market. Gastroenterology Review/Przegląd Gastroenterologiczny, 4(2), pp.71-73.
MLA
Gabryelewicz, Antoni. "Lanzul – eleven years after introduction to the Polish pharmaceutical market." Gastroenterology Review/Przegląd Gastroenterologiczny, vol. 4, no. 2, 2009, pp. 71-73.
Vancouver
Gabryelewicz A. Lanzul – eleven years after introduction to the Polish pharmaceutical market. Gastroenterology Review/Przegląd Gastroenterologiczny. 2009;4(2):71-73.
The positive effects of multicentre clinical trials for treatment of gastric-duodenal ulcer and oesophageal reflux disease with Lanzul performed in Poland are described.